Medtronic, Inc. (MDT) Analyst Day Provides Long Range Plan for Reaching Higher Growth Levels - UBS
Tweet Send to a Friend
UBS analyst Matthew Taylor reiterated a Buy rating and $123.00 price target on Medtronic, Inc. (NYSE: MDT) after the company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
